Ionis (NASDAQ: IONS) EVP reports stock sale and PRSU, RSU grants
Rhea-AI Filing Summary
Ionis Pharmaceuticals EVP Research Eric Swayze reported equity award activity and related stock sales. On January 15, 2026, restricted stock units vested, resulting in the acquisition of 21,366 shares of common stock at $0.0 per share, after which he held 51,819 shares directly. On January 16, 2026, he sold 9,884 shares of common stock at a weighted average price of $75.34 in an automatic sale to cover tax withholding, leaving 41,935 shares held directly. An account for his son held 318 shares after a sale of 49 shares.
He received a grant of 25,800 performance restricted stock units, representing the maximum earnable based on a three-year total shareholder return performance period, and 9,675 additional restricted stock units. His son was granted 225 restricted stock units. Each unit represents a contingent right to one share of Ionis common stock or its cash value, generally vesting in four equal annual installments.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 9,884 | $75.34 | $745K |
| Sale | Common Stock | 49 | $75.97 | $4K |
| Grant/Award | Performance Restricted Stock Units | 25,800 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 21,366 | $0.00 | -- |
| Grant/Award | Restricted Stock Unit | 9,675 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 111 | $0.00 | -- |
| Grant/Award | Restricted Stock Unit | 225 | $0.00 | -- |
| Exercise | Common Stock | 21,366 | $0.00 | -- |
| Exercise | Common Stock | 111 | $0.00 | -- |
Footnotes (1)
- Acquired pursuant to vesting and release of shares in accordance with Restricted Stock Unit awards. The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.26 to $75.48 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4. Grant to reporting person of Performance Restricted Stock Units (PRSUs) under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. The PRSUs may vest at the end of the three-year performance period following the date of grant based on the Issuer's relative total shareholder return as compared to a peer group of companies. The number of PRSUs reported represents the maximum that may be earned, which is 200% of the target number. No number of PRSUs is guaranteed to vest and the actual number of PRSUs that will vest at the end of the performance period may be anywhere from zero to the amount stated. Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. Grant to reporting person of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. Grant to reporting person's son of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan.
FAQ
What insider activity did Ionis (IONS) report for EVP Research Eric Swayze?
The filing shows that Eric Swayze, EVP Research at Ionis Pharmaceuticals, had restricted stock units vest into common shares, sold some of those shares to cover tax withholding obligations, and received new grants of performance restricted stock units and restricted stock units, including awards associated with an account for his son.
What new performance restricted stock units (PRSUs) were granted to Eric Swayze at Ionis?
Eric Swayze received a grant of 25,800 performance restricted stock units under the Ionis Amended and Restated 2011 Equity Incentive Plan. This number represents the maximum that may be earned, equal to 200% of the target amount, based on Ionis’s relative total shareholder return over a three-year performance period. The actual number that vests may range from zero up to 25,800 units.
What additional restricted stock units did Eric Swayze and his son receive from Ionis?
Eric Swayze was granted 9,675 restricted stock units under the Ionis Amended and Restated 2011 Equity Incentive Plan. His son was granted 225 restricted stock units under the same plan. Each unit represents a contingent right to receive one share of Ionis common stock or its cash value, generally vesting in four equal annual installments.
How do Eric Swayze’s Ionis restricted stock units vest and settle?
The restricted stock units generally vest in four equal annual installments. Upon vesting, they are paid out in whole shares of Ionis common stock or an equivalent cash value, as determined by the company.